AMCHAM’s Pharma Core Committee held a meeting on February 15th under the leadership of Mr. Umang Chaturvedi, Chairman – Pharma Committee, AMCHAM to discussion potential topics and speakers for future sessions. Suggestions could be focused on innovative procurement, intellectual property for quicker access to innovative products (IP), regulatory harmonization for the benefits of innovative products, market access for value of innovative products (NLEMP, patent product, TMR) and future of health. It was decided to share with all committee members and finalize two main issues as per consensus.
By joining AMCHAM India, you become part of an active and dynamic Apex Chamber of U.S. Industry in India with a membership base of more than 400 American companies in India. AMCHAM is an important voice for policy advocacy, a critical source for business intelligence, a vibrant platform for networking and expanding your business.